SUBSCRIBE
SUBSCRIBE

PRANA Biotechnology Provides Update on Research and Development Programs at Annual General Meeting

December 20, 2007 | 
1 min read
MELBOURNE, AUSTRALIA--(Marketwire - December 20, 2007) - Prana Biotechnology Limited (NASDAQ: PRAN) (ASX: PBT) today provided an update of current and future activities of the Company at the Annual General Meeting.
Events Australia
MORE ON THIS TOPIC
Organizing Solutions and organizer concept as a Management leadership taking charge as a leader sorting out diverse ropes into an organized patterns as a business concept for strategy and control.
FDA
JPM26: Beam, Cabaletta, More Zero In on Regulatory Alignment After Tumultuous Year
January 19, 2026
 · 
6 min read
 · 
Heather McKenzie
Scenic view of downtown San Francisco California USA
Business
JPM26 Day 2: Companies Lay Out Near-Term Revenue, Longer-Term Business Goals
January 14, 2026
 · 
4 min read
 · 
Tristan Manalac
This 3D render features human icons arranged side by side and in a line. Among them, one icon at the front shines brightly, symbolizing leadership and innovation. The visual presents a powerful metaphor for leadership, innovation, and making a difference, making it ideal for themes related to leadership and inspiration in the business world.
obesity
JPM26: Novartis Doesn’t Have a GLP-1. They Don’t Miss It In a World Of Me-Toos
January 13, 2026
 · 
3 min read
 · 
Annalee Armstrong
South San Francisco, CA, USA - May 1, 2022: Exterior view of the Merck Researches Laboratories in South San Francisco, California. Merck & Co., Inc. is a global pharmaceutical company headquartered in Rahway, New Jersey. The company does business as Merck Sharp & Dohme (MSD) outside the United States and Canada.
Events
JPM26: Confident Merck Sees Growth Through Keytruda Loss of Exclusivity
January 13, 2026
 · 
1 min read
 · 
Heather McKenzie